Sørensen, Holger J2; Mortensen, Erik L3; Reinisch, June M3; Mednick, Sarnoff A3
1 Psykiatrisk Center Amager, Mental Health Services, The Capital Region of Denmark2 Psykiatrisk Center København, Mental Health Services, The Capital Region of Denmark3 unknown
BACKGROUND: Disturbances in the central nervous system originating during foetal life may increase the risk of schizophrenia. AIMS: To illuminate the hypothesis that prenatal exposure to analgesics may affect foetal neurodevelopment, leading to increased risk of schizophrenia in adulthood. METHOD: Using data from the Copenhagen Perinatal Cohort and from the Danish Psychiatric Central Register, we studied the relationship between prenatal exposure to analgesics and the risk of schizophrenia. The effect of prenatal exposure was adjusted for parental history of schizophrenia, second-trimester viral infections, concomitant drug treatment during pregnancy, an index of pregnancy complications, parental social status and parental age. RESULTS: In a risk set of 7999 individuals, 116 cases of schizophrenia were found (1.5%). Prenatal exposure to analgesics in the second trimester was associated with an elevated risk (adjusted odds ratio 4.75, 95% CI1.9-12.0). Independent of the covariates, the effect remained statistically significant. CONCLUSIONS: Independent of a wide range of possible confounders, a significant association between second-trimester exposure to analgesics and increased risk of schizophrenia was observed.
British Journal of Psychiatry, 2004, Vol 185, p. 366-71
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.